Core Viewpoint - The A-share medical device sector experienced a short-term surge, with notable stocks such as Nanwei Co., Ltd. hitting the daily limit, alongside significant increases in stocks like Haobio, Shuoshi Biology, Zhengchuan Co., Ltd., Rejing Biology, and Libang Instruments, following the approval of measures by the National Medical Products Administration to optimize lifecycle regulation and support innovation in high-end medical devices [1] Group 1 - The A-share medical device sector saw a short-term rally [1] - Nanwei Co., Ltd. reached the daily limit, indicating strong investor interest [1] - Other companies such as Haobio, Shuoshi Biology, Zhengchuan Co., Ltd., Rejing Biology, and Libang Instruments also experienced significant price increases [1] Group 2 - The National Medical Products Administration approved measures aimed at optimizing lifecycle regulation [1] - The new measures are designed to support innovation in high-end medical devices [1]
A股医疗器械板块短线拉升,南卫股份涨停,浩欧博、硕世生物、正川股份、热景生物、理邦仪器等纷纷走高。消息面上,国家药监局审议通过《关于优化全生命周期监管支持高端医疗器械创新发展的举措》。